West Pharmaceutical Services FR revenue
FR revenue at West Pharmaceutical Services came to $226.6M for the fiscal year to 31 Dec 2025, down 6.4% from a year earlier.
As West Pharmaceutical Services reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 17 Feb 2026.
By fiscal year
| Period ending | FR revenue | Change on a year | Filed |
|---|---|---|---|
| 31 Dec 2025 | $226.6M | down 6.4% | 17 Feb 2026 |
| 31 Dec 2024 | $242.2M | down 14.4% | 18 Feb 2025 |
| 31 Dec 2023 | $282.9M | up 18.9% | 20 Feb 2024 |
| 31 Dec 2022 | $237.9M | up 11.7% | 21 Feb 2023 |
| 31 Dec 2021 | $213.0M | up 23.3% | 22 Feb 2022 |
| 31 Dec 2020 | $172.7M | up 14.7% | 23 Feb 2021 |
| 31 Dec 2019 | $150.6M | up 3.9% | 24 Feb 2020 |
| 31 Dec 2018 | $145.0M | up 1.7% | 28 Feb 2019 |
| 31 Dec 2017 | $142.6M | — | 26 Feb 2018 |
Definition
Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.
Other operating KPIs of West Pharmaceutical Services: Proprietary Products revenue · West Vantage revenue · United States revenue · Germany revenue · Ireland revenue · financial statements
Every KPI and segment of WST, in the terminal.
Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.
